Submits FDA Filing July 14, 2022 26th worldwide patent and the first patent issued from Lexarias seventh patent family Lexarias Human Nicotine Study Nearing Start Date July 13, 2022 Lexaria is targeting the oral nicotine pouch category, one of the fastest growing segments of the nicotine industry Lexaria Granted Patent for Use of DehydraTECH to Deliver Antiviral Drugs April 21, 2022 25th patent grant is Lexarias first-ever patent for the enhanced delivery of antivirals Lexarias Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results April 14, 2022 Data From This Human Study, Together With the Findings From Lexarias Other Previously Announced Successful Studies, Intended To Support the Companys Plans To Seek Approvals by the U.S
Room temperature storage is acceptable only for very short periods
For educational use, it is important to follow the labeled precautions, warnings, and administration instructions provided by the manufacturer
Medicaid GLP-1 Coverage for Children Under 21 Children and young adults under 21 have stronger protections under the federal EPSDT (Early and Periodic Screening, Diagnostic, and Treatment) mandate
Not a drug, supplement, or medical device
